2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

Bubbles have formed throughout stock market history. The actual bubble, and even the circumstances causing it, can change.

These three stocks are compelling buys for very different reasons. Market timing doesn't work, not consistently anyway. While ...

Recordati Rare Diseases Inc. today announced the presentation of new data related to its growing portfolio of treatments for rare hematologic disorders at the 67th American Society of Hematology (ASH) ...

Stocks have soared so far this year, but Rockland Trust vice president and portfolio manager Michael Sayers warns that he ...

Initial GDP estimates rely on incomplete survey data—less than half from actual three-month surveys—with the rest from extrapolations. The Bureau of Economic Analysis refines these estimates at the ...

Eric’s risk/reward market framework… why it means he won’t buy today’s AI darlings… nosebleed market valuations… a check-in ...

After an era of exuberance, expansion and ‘rockstar’ roles, sustainability in private markets is being more closely tethered ...

The Fiserv crash calls attention to other popular stocks with sell ratings and helps investors manage risk. Click here to see ...

Although Kimberly-Clark suffered a huge blow after announcing its Kenvue buyout, KMB stock is flashing a quantitative ...

Our blueprint unfolds in four overlapping phases—each grounded in neuroscience, real-world examples, and scalable digital ...

Experts believe that AI will grow into a multitrillion-dollar industry. It's exciting, to say the least. But much of AI's ...